NORMA DAVIS: Open Payments
NPI 1538570619 · YONKERS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,228 in 260 payments from 31 companies in 2025. Trend: 2023 $5,304 · 2024 $4,943 · 2025 $5,228
Food & beverage: $5,228
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $687 |
| Amgen Inc. | 29 | $555 |
| Novo Nordisk Inc | 16 | $373 |
| GlaxoSmithKline, LLC. | 15 | $342 |
| AstraZeneca Pharmaceuticals LP | 13 | $331 |
| GENZYME CORPORATION | 16 | $301 |
| Esperion Therapeutics, Inc. | 10 | $255 |
| Abbott Laboratories | 9 | $205 |
| Aimmune Therapeutics, Inc. | 11 | $202 |
| Astellas Pharma US Inc | 6 | $186 |
Products named: DUPIXENT, REXULTI, NEXLETOL, VRAYLAR, EVENITY, TEZSPIRE, Wegovy, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
